| Robert Connell, PSYD | |
|
1301 Ks Hwy 264, Larned, KS 67550-9365 | |
| (620) 285-4229 | |
| (620) 285-4509 |
| Full Name | Robert Connell |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 1301 Ks Hwy 264, Larned, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619921483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 1311 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Connell, PSYD 1301 Ks Hwy 264, Larned, KS 67550-9365 Ph: (620) 285-4229 | Robert Connell, PSYD 1301 Ks Hwy 264, Larned, KS 67550-9365 Ph: (620) 285-4229 |
News Archive
"World Bank President Robert Zoellick on Wednesday called on economists to rethink the way they look at issues affecting developing nations and said he was overhauling the way his institution approached research," Reuters reports (Wroughton, 9/29).
Depression and anxiety do not seem to interfere with the amount of weight loss or the improvement of obesity-related conditions after bariatric surgery, according to a new study of more than 25,000 patients presented here at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.
Freely giving researchers the tools and knowledge to tackle rare and orphaned diseases is the mission of UNC Catalyst, a new endeavor the University of North Carolina at Chapel Hill has launched with a $2 million grant from the Eshelman Institute for Innovation.
› Verified 1 days ago
Dr. Robin L. Karp, PSYD, L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Highway 264, Larned, KS 67550 Phone: 620-285-4703 | |
Lakshmi Subramanian, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4453 | |
Dr. Rebecca Anne Farr, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Highway 264, Larned, KS 67550 Phone: 620-285-4836 | |
Reba Glidewell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4022 Fax: 620-285-4249 | |
Debra Lynn Vondracek, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4711 | |
John Raeburn Reid, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4065 Fax: 620-285-4249 | |
Christina Eugenia Rudawski, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4506 |